Hepatic Veno-occlusive disease (VOD) in multiple myeloma patient receiving Belantamab Mafodotin.

MLA

Pessach, Ilias, et al. “Hepatic Veno-Occlusive Disease (VOD) in Multiple Myeloma Patient Receiving Belantamab Mafodotin.” Leukemia & Lymphoma, vol. 64, no. 4, Apr. 2023, pp. 904–06. EBSCOhost, https://doi.org/10.1080/10428194.2023.2179362.

APA

Pessach, I., Argyrakopoulou, G., Petropoulos, F., Rapti, I., Danglis, F., Trajce, E., & Chandrinou, E. (2023). Hepatic Veno-occlusive disease (VOD) in multiple myeloma patient receiving Belantamab Mafodotin. Leukemia & Lymphoma, 64(4), 904–906. https://doi.org/10.1080/10428194.2023.2179362

Chicago

Pessach, Ilias, Georgia Argyrakopoulou, Fotios Petropoulos, Irene Rapti, Fotios Danglis, Enkeleida Trajce, and Eleni Chandrinou. 2023. “Hepatic Veno-Occlusive Disease (VOD) in Multiple Myeloma Patient Receiving Belantamab Mafodotin.” Leukemia & Lymphoma 64 (4): 904–6. doi:10.1080/10428194.2023.2179362.